| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03639045.2015.1137306 |
| P698 | PubMed publication ID | 26716613 |
| P2093 | author name string | Tejal Gandhi | |
| Nirav Patel | |||
| Mukesh Gohel | |||
| Lalji Baldaniya | |||
| Vaishali Thakkar | |||
| Viral Metalia | |||
| P2860 | cites work | The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles | Q46559872 |
| Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose | Q46847508 | ||
| Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system | Q46890444 | ||
| Thermally reversible in situ gelling carbamazepine liquid suppository | Q46901862 | ||
| Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. | Q51537837 | ||
| Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. | Q53856427 | ||
| Ophthalmic drug dosage forms: characterisation and research methods. | Q55058119 | ||
| Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology | Q57184837 | ||
| Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system | Q57362785 | ||
| In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design | Q33573509 | ||
| Thermoresponsive hydrogels in biomedical applications | Q34690750 | ||
| In situ-forming hydrogels--review of temperature-sensitive systems | Q35857106 | ||
| A review of poloxamer 407 pharmaceutical and pharmacological characteristics. | Q36649745 | ||
| In situ-forming hydrogels for sustained ophthalmic drug delivery | Q36919001 | ||
| Pharmaceutical quality by design: product and process development, understanding, and control | Q37054214 | ||
| Nanomedicines for ocular NSAIDs: safety on drug delivery | Q37430580 | ||
| In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. | Q38152173 | ||
| Ophthalmic drug delivery systems--recent advances | Q41736662 | ||
| A controlled-release strategy for the generation of cross-linked hydrogel microstructures | Q42833453 | ||
| A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery | Q43147732 | ||
| In vitro skin permeation of estradiol from various proniosome formulations | Q43543122 | ||
| Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. | Q43715309 | ||
| In vitro release and characterization of chitosan films as dexamethasone carrier | Q44010864 | ||
| New vehicle based on a microemulsion for topical ocular administration of dexamethasone. | Q45170985 | ||
| Quality by design - Spray drying of insulin intended for inhalation | Q45791591 | ||
| Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model | Q46091281 | ||
| A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties | Q46470964 | ||
| Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis | Q46509770 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 1406-1423 | |
| P577 | publication date | 2015-12-30 | |
| P1433 | published in | Drug Development and Industrial Pharmacy | Q5308840 |
| P1476 | title | Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept | |
| P478 | volume | 42 |
| Q57291071 | Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review |
| Q51787921 | Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. |
| Q94486029 | In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management |
| Q43714357 | Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. |
Search more.